Ceftobiprole medocaril sodium 667 MG Injection — RxCUI 2703561
RxNorm drug concept · Semantic clinical drug
RxCUI 2703561
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2703561
Official nameCeftobiprole medocaril sodium 667 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asceftobiprole medocaril sodium 667 MG (equivalent to ceftobiprole 500 MG) Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Ceftobiprole medocaril sodium 667 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ceftobiprole medocaril sodium 667 MG Injection
RxCUI 2703561 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Ceftobiprole
2691333IN -
Ceftobiprole medocaril sodium
2691334PIN
-
Ceftobiprole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zevtera
2703562BN
-
Zevtera
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ceftobiprole Injection
2703558SCDF -
Ceftobiprole medocaril sodium Injection
2703560SCDFP -
Ceftobiprole Injectable Product
2703557SCDG -
Ceftobiprole medocaril sodium Injectable Product
2703559SCDGP -
Ceftobiprole Injection [Zevtera]
2703565SBDF -
Ceftobiprole medocaril sodium Injection [Zevtera]
2703566SBDFP -
Zevtera Injectable Product
2703564SBDG -
Injection
1649574DF - +1 more in this family
-
Ceftobiprole Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ceftobiprole medocaril sodium 667 MG
2703556SCDC -
Ceftobiprole medocaril sodium 667 MG Injection [Zevtera]
2703567SBD -
Ceftobiprole medocaril sodium 667 MG [Zevtera]
2703563SBDC
-
Ceftobiprole medocaril sodium 667 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ceftobiprole medocaril sodium 667 MG
SCDC · 2703556 -
Ceftobiprole Injection
SCDF · 2703558 -
Ceftobiprole medocaril sodium Injection
SCDFP · 2703560 -
Ceftobiprole Injectable Product
SCDG · 2703557 -
Ceftobiprole medocaril sodium Injectable Product
SCDGP · 2703559
Brand-Name Concepts
-
Ceftobiprole medocaril sodium 667 MG Injection [Zevtera]
SBD · 2703567 -
Ceftobiprole medocaril sodium 667 MG [Zevtera]
SBDC · 2703563 -
Ceftobiprole Injection [Zevtera]
SBDF · 2703565 -
Ceftobiprole medocaril sodium Injection [Zevtera]
SBDFP · 2703566 -
Zevtera Injectable Product
SBDG · 2703564 -
Zevtera
BN · 2703562
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2703561 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68547-0578-10 | 10 VIAL, GLASS in 1 BOX (68547-578-10) / 1 INJECTION, POWDE... | ZEVTERA | La Jolla Pharmaceutical Company | 2025-04-01 |
Observed labelers:
La Jolla Pharmaceutical Company (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0681 | Inj ceftobipole medocarl 3mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.